Brown Brothers Harriman & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,217
| Closed | -$1.21M | – | 1366 |
|
|
2019
Q3 | $1.21M | Buy |
12,217
+2,159
| +21% | +$205K | 0.01% | 210 |
|
|
2019
Q2 | $930K | Buy |
10,058
+406
| +4% | +$38.6K | 0.01% | 223 |
|
|
2019
Q1 | $911K | Sell |
9,652
-449
| -4% | -$39.3K | 0.01% | 213 |
|
|
2018
Q4 | $647K | Buy |
10,101
+127
| +1% | +$9.38K | ﹤0.01% | 221 |
|
|
2018
Q3 | $893K | Buy |
9,974
+712
| +8% | +$62.9K | 0.01% | 208 |
|
|
2018
Q2 | $736K | Sell |
9,262
-188
| -2% | -$15.6K | ﹤0.01% | 202 |
|
|
2018
Q1 | $843K | Buy |
9,450
+96
| +1% | +$9.22K | ﹤0.01% | 200 |
|
|
2017
Q4 | $976K | Buy |
9,354
+158
| +2% | +$17.8K | 0.01% | 187 |
|
|
2017
Q3 | $1.34M | Sell |
9,196
-310
| -3% | -$42.2K | 0.01% | 158 |
|
|
2017
Q2 | $1.24M | Buy |
9,506
+169
| +2% | +$20.7K | 0.01% | 155 |
|
|
2017
Q1 | $1.16M | Buy |
9,337
+110
| +1% | +$13.2K | 0.01% | 159 |
|
|
2016
Q4 | $1.07M | Sell |
9,227
-15,459
| -63% | -$1.72M | 0.01% | 161 |
|
|
2016
Q3 | $2.58M | Sell |
24,686
-10,429
| -30% | -$1.13M | 0.01% | 123 |
|
|
2016
Q2 | $3.46M | Sell |
35,115
-424
| -1% | -$43.9K | 0.02% | 111 |
|
|
2016
Q1 | $3.56M | Buy |
35,539
+21
| +0.1% | +$2.16K | 0.02% | 107 |
|
|
2015
Q4 | $4.25M | Sell |
35,518
-2,838
| -7% | -$328K | 0.02% | 103 |
|
|
2015
Q3 | $4.15M | Sell |
38,356
-1,357
| -3% | -$168K | 0.02% | 105 |
|
|
2015
Q2 | $4.6M | Sell |
39,713
-1,054
| -3% | -$120K | 0.02% | 100 |
|
|
2015
Q1 | $4.7M | Buy |
40,767
+591
| +1% | +$70.6K | 0.02% | 101 |
|
|
2014
Q4 | $4.49M | Sell |
40,176
-6,912
| -15% | -$729K | 0.02% | 107 |
|
|
2014
Q3 | $4.46M | Sell |
47,088
-15,950
| -25% | -$1.44M | 0.02% | 111 |
|
|
2014
Q2 | $5.41M | Buy |
63,038
+21,082
| +50% | +$1.6M | 0.02% | 109 |
|
|
2014
Q1 | $2.93M | Buy |
41,956
+2,958
| +8% | +$234K | 0.01% | 125 |
|
|
2013
Q4 | $3.29M | Buy |
38,998
+5,338
| +16% | +$422K | 0.01% | 120 |
|
|
2013
Q3 | $2.59M | Sell |
33,660
-17,708
| -34% | -$1.24M | 0.01% | 126 |
|
|
2013
Q2 | $3M | Buy |
+51,368
| New | +$3.09M | 0.01% | 137 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Brown Brothers Harriman & Co's CELG Position: Q4 2019 in Review
Brown Brothers Harriman & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 12,217 shares — an estimated $1.21M sold.
Brown Brothers Harriman & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.41M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Brown Brothers Harriman & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 12,217 Celgene Corp shares in Q4 2019, an estimated $1.21M.
- Brown Brothers Harriman & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Brown Brothers Harriman & Co's Celgene Corp position peaked at $5.41M in Q2 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Brown Brothers Harriman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.